JAPANESE IMMUNOTHERAPY & REGENERATIVE MEDICINE

About Us

Saisei Mirai is a Japanese medical institution specializing in immunotherapy, regenerative medicine, and advanced integrative treatment strategies. Our work is supported by clinical experience and academic collaborations.

Our CEO Locations Universities

Our CEO

Dr. Toshio Inui — clinical leadership and research direction.

Dr. Toshio Inui

CEO of the Saisei Mirai Clinic group Medical Doctor, PhD Kagoshima University, Visiting Professor

Graduated from Kyoto Prefectural University of Medicine in 1978. At the age of 33, after gaining experience working in the internal medicine department at a general hospital as a physician, he established Inui Clinic for the treatment of internal diseases.

He soon came to develop a reputation for careful and heartwarming medical examinations which made him popular with patients.

After the loss of his father due to cancer, he came to realize the limitations of conventional therapies for cancer such as surgery, chemotherapy, anti-cancer drugs and radiation therapy, and he started his new practice specializing in immunotherapy for cancer. He also changed his clinic name to Inui Immunotherapy Cancer Clinic.

Currently the clinic is cooperating with medical institutions in Japan as well as overseas, and carrying out research and development of new immunotherapies, such as GcMAF, autologous cancer vaccines, and hyper T/NK cell therapy.

Career history

1978

Graduated from Kyoto Prefectural University of Medicine.

1978

University Hospital, Kyoto Prefectural University of Medicine. Worked in the first course for internal medicine.

1980

Japanese Red Cross Kyoto Daini Hospital. Worked in the emergency medical care center.

1980

Japanese Red Cross Kyoto Daini Hospital. Worked in internal medicine.

1987

Opened Inui Cancer Immunotherapy Clinic in Osaka, Japan.

2009

Incorporated the medical institution Saisei Mirai. Inaugurated as the chairman of the board of directors.

2009

Opened Keihan Saisei Medical Center in Osaka, Japan.

2010

Opened Saisei Mirai Kobe Clinic, Kobe, Japan.

2010

Began developing Second Generation High Dose GcMAF in collaboration with Tokushima University in Japan.

2011

Began production of 2nd Generation High Dose GcMAF in our Cell Processing Center (CPC) followed by clinical use for patients.

2012

Opened Saisei Mirai Tokyo Clinic, Tokyo, Japan.

2013

Opened Saisei Mirai Keihan Clinic, Osaka, Japan.

2013

Kyoto Prefectural University of Medicine, served as a visiting professor.

2018

Ritsumeikan University, served as a visiting professor.

2020

Kagoshima University, served as a visiting professor.

2023

Opened Saisei Serbia Clinic.

2024

Opening Saisei Lithuania Clinic (pending).

Our Locations

Saisei Mirai clinics and partner centers providing access to our treatments.

Keihan Clinic, Osaka

JAPAN

Kobe Clinic

JAPAN

Tokyo Science Clinic

JAPAN

Cell Processing Center

OSAKA

Saisei Pharma

Online Store Available worldwide

Saisei Hawaii

Company & Online Store Available in the USA

Saisei Australia

Company & Online Store Available in Australia and New Zealand

Saisei Serbia

Clinic Contact details

Universities We Collaborate With

Academic collaborations supporting our research in immunology and regenerative medicine.

Tokushima University Campus

Tokushima University

Joint research in immunology and regenerative medicine.

Konan University Campus

Konan University

Collaborative research programs.

Tottori University Campus

Tottori University

Global scientific collaboration.

Kobe University Campus

Kobe University

Medical and translational research projects.

Kyoto Prefectural University of Medicine Campus

Kyoto Prefectural University of Medicine

Clinical research collaborations.

Kagoshima University Campus

Kagoshima University

Joint publications and conferences.

error: Content is protected !!